Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.
Current Value
$2.551 Year Return
Current Value
$2.551 Year Return
Market Cap
$98.86M
P/E Ratio
-1.34
1Y Stock Return
-9.79%
1Y Revenue Growth
-100.00%
Dividend Yield
0.00%
Price to Book
2.0
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the third quarter ended September 30, 2024.
Finnhub
Leap Therapeutics Reports Third Quarter 2024 Financial Results Cambridge, MA - November 13, 2024 - Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and...
Yahoo
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that enrollment of 188 patients has been completed in the randomized controlled Part B of the DeFianCe study evaluating DKN-01, Leap's anti-Dickkopf-1 (DKK1) antibody, in combination with standard of care bevacizumab and chemotherapy as a second-line treatment for patients with advanced colorectal cancer (CRC).
Finnhub
Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients Cambridge, MA - September...
Finnhub
CAMBRIDGE - Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the second quarter ended June 30,...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GTE | -19.33% | $228.24M | +0.97% | 0.00% |
NEUE | -18.59% | $41.96M | -33.09% | 0.00% |
STNG | -16.72% | $2.81B | -6.67% | 2.97% |
SU | -15.37% | $52.24B | +25.02% | 3.90% |
BSM | -15.18% | $3.23B | -12.29% | 10.44% |
TRGP | -14.52% | $45.29B | +138.12% | 1.32% |
CVE | -13.47% | $29.59B | -7.08% | 2.92% |
LNG | -13.44% | $50.48B | +26.56% | 0.81% |
FTI | -13.05% | $12.77B | +43.50% | 0.66% |
ASC | -12.64% | $497.50M | -11.99% | 9.03% |
TK | -12.52% | $725.50M | +8.67% | 0.00% |
PBA | -12.37% | $25.06B | +31.86% | 4.62% |
IMO | -12.24% | $40.35B | +35.46% | 2.20% |
PAGP | -12.14% | $3.79B | +21.07% | 0.00% |
FRO | -12.13% | $4.35B | -10.94% | 9.87% |
TCTM | -12.03% | $7.57M | -41.30% | 0.00% |
PAA | -12.02% | $12.54B | +14.45% | 7.13% |
GSL | -11.95% | $805.69M | +29.03% | 6.74% |
PRT | -11.85% | $48.51M | -17.78% | 10.36% |
WES | -11.80% | $14.43B | +33.37% | 8.38% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KRP | -0.01% | $1.30B | +3.95% | 10.90% |
COR | 0.03% | $48.41B | +23.04% | 0.84% |
PSQH | 0.03% | $76.13M | -59.59% | 0.00% |
IFRX | -0.05% | $121.30M | +44.06% | 0.00% |
MTRX | -0.05% | $364.83M | +33.47% | 0.00% |
ORKA | -0.05% | $717.47M | +69.86% | 0.00% |
NFE | 0.05% | $2.39B | -74.26% | 3.14% |
CREG | -0.06% | $6.22M | -36.05% | 0.00% |
BEKE | 0.06% | $23.09B | +27.26% | 0.00% |
OCFT | 0.07% | $81.68M | -30.63% | 0.00% |
TRVG | 0.08% | $37.49M | -36.70% | 0.00% |
AVD | 0.09% | $176.47M | -33.37% | 1.47% |
OHI | 0.09% | $10.84B | +26.39% | 6.62% |
HWKN | 0.09% | $2.68B | +105.84% | 0.52% |
PSN | -0.10% | $10.55B | +57.16% | 0.00% |
OKLO | -0.12% | $3.08B | +143.89% | 0.00% |
NTR | -0.12% | $23.13B | -15.56% | 4.62% |
PSLV | 0.13% | - | - | 0.00% |
RGA | -0.13% | $15.09B | +41.90% | 1.52% |
HP | -0.14% | $3.40B | -6.98% | 2.86% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FBIO | 33.08% | $43.27M | -28.64% | 0.00% |
APPS | 27.88% | $152.48M | -70.95% | 0.00% |
IBN | 26.52% | $105.19B | +34.81% | 0.78% |
EPRT | 26.45% | $5.87B | +41.29% | 3.42% |
TXG | 26.41% | $1.61B | -69.34% | 0.00% |
FOLD | 26.21% | $2.84B | -10.71% | 0.00% |
BLFS | 26.11% | $1.18B | +87.10% | 0.00% |
NTLA | 25.99% | $1.41B | -54.40% | 0.00% |
TMO | 25.91% | $197.41B | +5.86% | 0.30% |
CRSP | 25.73% | $3.95B | -34.33% | 0.00% |
ADPT | 25.64% | $644.92M | +2.82% | 0.00% |
PLRX | 25.57% | $781.97M | -7.75% | 0.00% |
NNN | 25.39% | $8.19B | +10.66% | 5.28% |
CLNE | 25.32% | $605.57M | -22.35% | 0.00% |
SEG | 25.25% | $344.46M | +21.11% | 0.00% |
BKE | 25.25% | $2.42B | +33.07% | 2.93% |
BBIO | 25.05% | $4.39B | -21.22% | 0.00% |
ARVN | 24.92% | $1.73B | +17.28% | 0.00% |
SR | 24.88% | $4.08B | +16.74% | 4.23% |
GTY | 24.80% | $1.80B | +12.49% | 5.47% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBE | -22.81% | $50.92M | 0.77% |
COMT | -21.24% | $842.63M | 0.48% |
GSG | -20.98% | $935.59M | 0.75% |
DBO | -20.43% | $218.38M | 0.77% |
DBC | -18.90% | $1.41B | 0.87% |
PDBC | -18.47% | $4.47B | 0.59% |
BTAL | -17.98% | $379.51M | 1.43% |
USCI | -17.85% | $185.92M | 1.07% |
FTGC | -15.93% | $2.21B | 1.02% |
VIXY | -15.67% | $195.31M | 0.85% |
PREF | -13.52% | $1.01B | 0.55% |
BCI | -12.35% | $1.20B | 0.26% |
USDU | -12.17% | $201.83M | 0.5% |
CTA | -11.88% | $359.48M | 0.78% |
UUP | -11.72% | $359.07M | 0.77% |
BCD | -11.56% | $245.10M | 0.3% |
DBMF | -11.29% | $1.02B | 0.85% |
EQLS | -11.22% | $8.88M | 1% |
GCC | -10.97% | $135.83M | 0.55% |
JBBB | -8.27% | $1.27B | 0.49% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
QQA | 34.84% | $135.25M | 0% |
PINK | 33.33% | $163.05M | 0.5% |
BSJQ | 28.83% | $776.92M | 0.42% |
IBDW | 28.45% | $1.18B | 0.1% |
DFIP | 28.37% | $787.66M | 0.11% |
IBDU | 28.30% | $2.00B | 0.1% |
DIAL | 27.91% | $368.94M | 0.28% |
JPMB | 27.89% | $587.09M | 0.39% |
DFAR | 27.55% | $1.21B | 0.19% |
IBB | 26.95% | $6.64B | 0.45% |
FLHY | 26.65% | $593.82M | 0.4% |
FRI | 26.40% | $186.55M | 0.5% |
BBRE | 26.16% | $979.60M | 0.11% |
RWR | 26.12% | $1.90B | 0.25% |
RSPA | 26.05% | $272.75M | 0% |
USRT | 26.03% | $2.93B | 0.08% |
INDS | 25.99% | $175.86M | 0.55% |
LDSF | 25.94% | $131.22M | 0.75% |
XBI | 25.89% | $6.75B | 0.35% |
IYR | 25.89% | $4.67B | 0.39% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SGOV | <0.01% | $27.69B | 0.09% |
MLPA | 0.05% | $1.65B | 0.45% |
FXI | -0.27% | $7.82B | 0.74% |
CRPT | 0.34% | $97.94M | 0.85% |
AMLP | 0.41% | $9.58B | 0.85% |
UNG | -0.43% | $928.64M | 1.06% |
TPMN | 0.46% | $40.73M | 0.65% |
MCHI | -0.53% | $5.59B | 0.59% |
FLCH | -0.71% | $152.40M | 0.19% |
FMF | -0.79% | $243.44M | 0.95% |
IBDP | 0.82% | $2.05B | 0.1% |
CSHI | 0.84% | $486.73M | 0.38% |
XBIL | 0.88% | $637.84M | 0.15% |
CXSE | 0.91% | $412.54M | 0.32% |
IXC | 1.17% | $2.23B | 0.41% |
FLRN | -1.20% | $2.34B | 0.15% |
CHIQ | 1.21% | $229.48M | 0.65% |
MINT | 1.30% | $11.62B | 0.35% |
BILZ | -1.32% | $553.02M | 0.14% |
IAK | -1.37% | $755.17M | 0.39% |